Coaching by messaging app moved blood pressure

Hypertension is a long-term condition whose outcomes depend heavily on what patients do between appointments: taking medication consistently, monitoring blood pressure, staying active and recognising symptoms. Conventional care struggles to support that daily work, and clinic contact is infrequent. Structured coaching models delivered through the phone people already use are an obvious candidate for filling the gap, but the question is whether they change measurable self-management behaviour and blood pressure rather than just satisfaction. This trial tested one such model in middle-aged and older adults already under community management for hypertension.

This was a single-centre randomised controlled trial in 250 middle-aged and elderly patients with hypertension, allocated to either conventional hypertension management or comprehensive management based on the E-Coach chronic disease model delivered via the WeChat platform, with 125 in each group. The primary outcomes were Chronic Disease Self-Management Study Measures scores and Patient Assessment of Chronic Illness Care scores. Secondary outcomes covered systolic and diastolic blood pressure and management outcomes including hospital visits, medication adherence and blood pressure control rates. Assessment was made after six months.

After six months the intervention group scored higher across all measured self-management dimensions, including cognitive symptom management and doctor-patient communication, and across every dimension of perceived chronic illness care — patient activation, service system and delivery design, goal setting and tailored care, problem solving and continuity, and follow-up and collaboration. Both systolic and diastolic blood pressure were lower in the intervention group. The intervention group also reported fewer outpatient visits, emergency visits and hospitalisations, with higher medication adherence and blood pressure control rates. Notably, reported exercise dimensions such as stretching, strength and aerobic activity showed the same median values in both groups.

The result is consistent with a broad body of work suggesting structured, frequent contact and goal setting improve chronic disease self-management, and it adds a blood pressure signal on top of the questionnaire gains. It does not isolate which ingredient mattered — the coaching structure, the platform, or simply more attention from the health service. An unblinded trial in which the intervention group knows it is being coached is vulnerable to reporting effects on self-report scales, though blood pressure and hospital use are harder to influence that way. Durability beyond six months is untested.

This is a reason to think that regular, structured digital contact with a healthcare team can support the daily habits that hypertension management depends on, and that the benefit may show up in blood pressure and not only in how supported people feel. It says nothing about doing this alone with an app and no clinical involvement, since the intervention sat inside an existing care pathway. The exercise dimensions did not separate between groups, so the gains here do not appear to be a training effect. Medication and blood pressure decisions remain matters for a clinician.